Lori Anne Kunkel - Director at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
ELVN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lori Anne Kunkel since 12 Feb 2025

Holdings reported by Lori Anne Kunkel for Enliven Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 31,172 $631,856 $20.27 17 Dec 2025 Indirect
Common Stock 30,712 $34,397 $1.12 17 Dec 2025 Direct
Stock Option (right to buy) 3,741 17 Dec 2025 Direct Common Stock

Transactions reported by Lori Anne Kunkel for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.